The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Compliance for Peptide Therapy and BPC 157 Holt Law Peptides Lack Reliable Safety Information, Watchdog Warns A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com FDA to weigh easing limits on unproven peptides